NEURAL IMPLANTS (BRAIN IMPLANTS) MARKET SIZE TO CROSS USD 7.2 BILLION BY 2025, GROWING AT A CAGR OF 11% DURING THE FORECAST PERIOD

Neural Implants Market Size, Share, Trends Analysis Report by End-users (Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers), Products (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)), Application (Chronic Pain, Parkinson’s Disease (PD), Epilepsy, and others), and Geography (APAC, North America, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

286 Pages

61 Tables

134 Charts

5 Regions

19 Countries

18 Companies

4 Market Segment

GLOBAL NEURAL IMPLANTS (BRAIN IMPLANTS) MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 7.2 Billion (2025)
CAGR 11% (2020–2025)
Base Year 2019
Forecast Year 2020–2025
Market Segments End-users (Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers), Products (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)), Application (Chronic Pain, Parkinson’s Disease (PD), Epilepsy, and others)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Turkey, South Africa, UAE, and Saudi Arabia

INDUSTRY INSIGHTS

The global neural implants or brain implants market size to cross over USD 7.2 billion by 2025, growing at a CAGR of close to 11% during the forecast period. The global brain implants market is one of the fastest-growing segments in the global neurological treatment devices industry. The growing prevalence of neurological diseases worldwide, coupled with rising awareness among patients about new treatment modalities for neurological disorders and the increasing availability of effective devices, is a major factor contributing to the industry growth. Neural implant technology is highly innovative and is expected to influence the existing treatment modalities of neuropathic disorders and chronic neuropathic pain. The introduction of neural implants has been a significant breakthrough in neurological treatment modalities with their high potential in minimizing the occurrence of adverse events associated with Parkinson’s Disease, chronic pain, epilepsy, and other neural disorders. Therefore, the adoption of neural implants is likely to increase at a phenomenal rate in the coming years.

With the outbreak of the COVID-19 pandemic, the global neural implants market witnessed a decline in demand in the first quarter of 2020. Many non-critical surgeries are postponed or delayed in the virus affected countries as most HCPs have been redeployed to critical departments to tackle the pandemic. Further, the utilization of neuromodulation procedures with neural implants is likely to decline in 2020 as the number of surgical procedures is estimated to decrease in the short term, therefore delaying the new purchase of these devices until the COVID-19 pandemic subsides.

SNIPPETS

  • The global neural implants market will witness double-digit growth during the forecast period due to the high prevalence of neurological diseases and the availability of the latest generation devices across the globe.
  • The increasing preference for MR-conditional brain implants is one of the key driving factors for the global neural implants market's growth.
  • The growing focus on developing paresthesia-free brain implants is likely to drive industry growth.
  • North America is expected to dominate the industry; however, APAC is expected to witness the highest growth rate over the forecast period with over 13%.

GLOBAL NEURAL IMPLANTS MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Product
  • End-users
  • Application
  • Geography

INSIGHTS BY PRODUCT

In 2019, the spinal cord stimulation (SCS) segment accounted for more than 62% of the global neural implants market share. The growth of the segment has been fueled primarily due to the increasing prevalence of neuropathic pain, particularly the upsurge of patients with failed back surgery syndrome (FBSS)/failed back syndrome (FBS), and the attempts to use strategies other than chronic opioid therapy for the treatment of chronic neuropathic pain. Implantable SCS systems are used to treat certain types of chronic pain, such as neuropathic pain. As an intervention for chronic pain, SCS has proven an effective alternative.

The deep brain stimulation (DBS) segment is expected to grow at a CAGR of close to 10% during 2019–2025. DBS is an effective treatment for common movement disorders and has been effective in modulating neural activity by delivering electrical stimulation to key brain structures. The long-term efficacy of stimulation in treating disorders dystonia, and essential tremors, has encouraged the application to a wide range of neurological and psychiatric conditions.

INSIGHTS BY APPLICATION

The chronic pain segment will cross USD 4 billion by 2025. According to the WHO, an estimated 22% of the world’s primary care patients have chronic debilitating pain making chronic pain a global challenge to be addressed by healthcare professionals. The incidence/prevalence of chronic pain is increasing rapidly worldwide. It affects 28−65% of the population in the US. Developing countries face a large burden of chronic pain than developed regions. Thus, the rising burden of chronic pain is likely to fuel the growth of the segment.

In 2019, the Parkinson's disease (PD) segment accounted for 20% of the market share. The growing geriatric population worldwide is one of the key factors placing more adults at risk of PD.

INSIGHTS BY END-USERS

In 2019, hospitals' end-user segment constituted over 56% of the global neural implants market share. Healthcare professionals in hospitals are using neural implants for treating symptoms associated with neuropathic pain and neurodegenerative disorders. The industry is growing at a healthy rate and is likely to grow during the forecast period. The high adoption of the latest generation implants and the increased preference among patients with an increased risk of neurological diseases for visiting hospitals for diagnosis and treatment contribute to the segment's growth.

The specialized neurological center segment will grow because of the availability of sophisticated infrastructure related to the diagnosis and treatment of neurological disorders in specialized neurological centers.

INSIGHTS BY GEOGRAPHY

The North America neural implants market will reach over USD 5 billion by 2025. The industry is expected to witness lucrative growth during the forecast period due to the rising technological advancements that influence the uptake of easy-to-use medical devices. The increased healthcare spending is further leading to the neural implants market growth in the region. The region is the single largest market for brain implants, becoming strategically important for several prominent market players such as Medtronic, Abbott, Boston Scientific, and others. Therefore, North America is witnessing a substantial number of product approvals over several years. The region is characterized by high penetration of advanced treatment solutions for neurological diseases. With favorable patient demography and the aging population, the region offers tremendous growth opportunities. Thereby the brain implants market is expected to continue to grow during the forecast period.

INSIGHTS BY VENDORS

The global neural implants market share is highly consolidated, with major vendors accounting for dominant shares. Key vendors are offering a broad range of conventional as well as latest-generation neural implants for end-users. Medtronic, Abbott, Boston Scientific, NEVRO, and LivaNova are the key players in the industry. These vendors compete based on technology advances, accuracy features, regulatory approvals, marketing strategies, and distribution channels. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on product innovation, strategic mergers & acquisitions, and R&D activities.

The global neural implants market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

By Product

  • F&B Spinal Cord Stimulation (SCS)
  • Deep Brain Stimulation (DBS)
  • Vagus Nerve Stimulation (VNS)

By Application

  • Chronic Pain
  • Parkinson’s Disease (PD)
  • Epilepsy
  • others

By End-user

  • Hospitals
  • Specialized Neurological Centers (SNCs)
  • Outpatient Surgery Centers

By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Turkey

Frequently Asked Questions

The global neural implants market size to reach close to USD 7.2 billion by 2025, growing at a CAGR of close to 11% during 2020-2025
The emergence of latest generation devices & technology and the promising rise of investigational Devices are expected to drive the market.
The APAC neural implants market is expected to observe an incremental growth of over $440 million by 2025.
The leading vendors in the global neural implants market are Medtronic, Abbott, Boston Scientific, and NEVRO are the key industry players.
Download Free Sample

The neural implants market by revenue is expected to grow at a CAGR of ≈11% during the period 2020–2025.

The following factors are likely to contribute to the growth of the neural implants market during the forecast period:

  • The emergence of Latest Generation Neural Implants
  • Promising Rise of Investigational Devices
  • Growing Popularity of MR-conditional Neural Implants

Base Year:                  2019

Forecast Year:           2020–2025

The study considers the present scenario of the neural implants market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

  • Medtronic
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Abbott
  • Boston Scientific
  • NEVRO
  • LivaNova

Other Prominent Vendors

  • Aleva Neurotherapeutics
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Beijing PINS Medical
  • Nalu Medical
  • NeuroPace
  • Nuvectra
  • Saluda Medical
  • SceneRay
  • Stimwave

Investigational Companies

  • GTX Medical
    • Business Overview
    • Investigational Products
  • MicroTransponder
  • Neuralink
  • SetPoint Medical
  • Synchron

By Product

  • F&B Spinal Cord Stimulation (SCS)
  • Deep Brain Stimulation (DBS)
  • Vagus Nerve Stimulation (VNS)

By Application

  • Chronic Pain
  • Parkinson’s Disease (PD)
  • Epilepsy
  • others

By End-user

  • Hospitals
  • Specialized Neurological Centers (SNCs)
  • Outpatient Surgery Centers

By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Turkey

 

1              Research Methodology

2              Research Objectives

3              Research Process

 

4              Scope & Coverage

4.1          Market Definition

4.1.1      Inclusions

4.1.2      Exclusions

 

4.2          Base Year

4.3          Scope of the Study

4.4          Market Segments

4.4.1      Market Segmentation by Product

4.4.2      Market Segmentation by Application

4.4.3      Market Segmentation by End-user

4.4.4      Market Segmentation by Geography

 

5             Report Assumptions & Caveats

5.1          Key Caveats

5.2          Currency Conversion

5.3          Market Derivation

 

6              Market at a Glance

 

7              Introduction

7.1          Neural Implants: An Overview

7.1.1      Background

7.1.2      Clinical Use of Neural implants

7.1.3      Neural Implants: Market Snapshot

 

8              Market Opportunities & Trends

8.1          Emergence of Latest Generation Neural Implants

8.2          Promising Investigational Devices

8.3          New Product Approvals/Launches

 

9              Market Growth Enablers

9.1          Rising Target Patient Pool Globally

9.2          Growing Popularity of MR-Conditional Neural Implants

9.3          Increasing Uptake of Minimally Invasive Pain Relief Treatment

9.4          Use of High-Frequenecy Neuromodulation Therapy

 

10           Market Restraints

10.1        Risks & Complications Associated With Neural Implants

10.1.1    Complications Associated with DBS

10.1.2    Complications Associated with SCS

10.1.3    Complications Associated with VNS

10.2        Stringent Regulations Associated With Neural Implants

10.3        Limited Availability of Skilled Neurologists/Neurosurgeons

10.4        High Cost of Neural Implants

 

11           Market Landscape

11.1        Market Overview

11.2        COVID-19 Impact on the Global Neural Implants Market

11.3        Market Size & Forecast

11.4        Five Forces Analysis

11.4.1    Threat of New Entrants

11.4.2    Bargaining Power of Suppliers

11.4.3    Bargaining Power of Buyers

11.4.4    Threat of Substitutes

11.4.5    Competitive Rivalry

 

12           Neural Implants Market by Product

12.1        Snapshot & Growth Engine

12.2        Overview

12.3        SCS

12.3.1    Overview

12.3.2    Size & Forecast

12.3.3    Geography Segmentation: Snapshot & Growth Engine

12.4        DBS

12.4.1    Overview

12.4.2    Size & Forecast

12.4.3    Geography Segmentation: Snapshot & Growth Engine

12.5        VNS

12.5.1    Overview

12.5.2    Size & Forecast

12.5.3    Geography Segmentation: Snapshot & Growth Engine

 

13           Neural Implants Market by Application

13.1        Snapshot & Growth Engine

13.2        Overview

13.3        Chronic Pain

13.3.1    Overview

13.3.2    Size & Forecast

13.4        Parkinson’s Disease

13.4.1    Overview

13.4.2    Size & Forecast

13.5        Epilepsy

13.5.1    Overview

13.5.2    Size & Forecast

13.6        Others

13.6.1    Overview

13.6.2    Size & Forecast

 

14           Neural Implants Market by End-User

14.1        Snapshot & Growth Engine

14.2        Overview

14.3        Hospitals

14.3.1    Overview

14.3.2    Size & Forecast

14.4        Specialized Neurological Centers

14.4.1    Overview

14.4.2    Size & Forecast

14.5        Outpatient Surgery Centers

14.5.1    Overview

14.5.2    Size & Forecast

 

15           Neural Implants Market by Geography

15.1        Snapshot & Growth Engine

15.2        Geographic Overview

 

16           North America

16.1        Overview

16.2        Size & Forecast

16.3        North America: Product Segmentation

16.3.1    Snapshot & Growth Engine

16.4        Key Countries

16.4.1    US: Neural Implants Market Size & Forecast

16.4.2    Canada: Size & Forecast

 

17           Europe

17.1        Overview

17.2        Size & Forecast

17.3        Europe: Product Segmentation

17.3.1    Snapshot & Growth Engine

17.4        Key Countries

17.4.1    Germany: Neural Implants Market Size & Forecast

17.4.2    France: Size & Forecast

17.4.3    UK: Neural Implants Market Size & Forecast

17.4.4    Italy: Size & Forecast

17.4.5    Spain: Neural Implants Market Size & Forecast

 

18           APAC

18.1        Overview

18.2        Size & Forecast

21.3        APAC: Product Segmentation    

21.3.1    Snapshot & Growth Engine        

18.4        Key Countries

18.4.1    Japan: Neural Implants Market Size & Forecast

18.4.2    China: Size & Forecast

18.4.3    Australia: Neural Implants Market Size & Forecast

18.4.4    South Korea: Size & Forecast

18.4.5    India: Neural Implants Market Size & Forecast

 

19           Latin America

19.1        Overview

19.2        Size & Forecast

19.3        Latin America: Product Segmentation

19.3.1    Snapshot & Growth Engine

19.4        Key Countries

19.4.1    Brazil: Neural Implants Market Size & Forecast

19.4.2    Mexico: Size & Forecast

19.4.3    Argentina: Neural Implants Market Size & Forecast

 

20           Middle East & Africa

20.1        Overview

20.2        Size & Forecast

20.3        Middle East & Africa: Product Segmentation

20.3.1    Snapshot & Growth Engine

20.4        Key Countries

20.4.1    Turkey: Neural Implants Market Size & Forecast

20.4.2    Saudi Arabia: Size & Forecast

20.4.3    South Africa: Neural Implants Market Size & Forecast

20.4.4    Iran: Market Size & Forecast

 

21           Competitive Landscape

21.1        Competition Overview

21.2        Market Share Analysis

21.2.1    Medtronic

21.2.2    Boston Scientific

21.2.3    Abbott

21.2.4    LivaNova

21.2.5    NEVRO

 

22           Key Company Profiles

22.1        Medtronic

22.1.1    Business Overview

22.1.2    Product Offerings

22.1.3    Key Strategies

22.1.4    Key Strengths

22.1.5    Key Opportunities

 

22.2        Abbott

22.2.1    Business Overview

22.2.2    Product Offerings

22.2.3    Key Strategies

22.2.4    Key Strengths

22.2.5    Key Opportunities

 

22.3        Boston Scientific

22.3.1    Business Overview

22.3.2    Product Offerings

22.3.3    Key Strategies

22.3.4    Key Strengths

22.3.5    Key Opportunities

 

22.4        NEVRO

22.4.1    Business Overview

22.4.2    Product Offerings

22.4.3    Key Strategies

22.4.4    Key Strengths

22.4.5    Key Opportunities

 

22.5        LivaNova

22.5.1    Business Overview

22.5.2    Product Offerings

22.5.3    Key Strategies

22.5.4    Key Strengths

22.5.5    Key Opportunities

 

23          OTHER PROMINENT VENDORS

23.1       Aleva Neurotherapeutics

23.1.1    Business Overview

23.1.2    Product Offerings

23.1.3    Key Strategies

23.1.4    Key Strengths

23.1.5    Key Opportunities

 

23.2      Beijing PINS Medical

23.2.1    Business Overview

23.2.2    Product Offerings

23.2.3    Key Strategies

23.2.4    Key Strengths

23.2.5    Key Opportunities

 

23.3        Nalu Medical

23.3.1    Business Overview

23.3.2    Product Offerings

23.3.3    Key Strategies

23.3.4    Key Strengths

23.3.5    Key Opportunities

 

23.4        NeuroPace

23.4.1    Business Overview

23.4.2    Product Offerings

23.4.3    Key Strategies

23.4.4    Key Strengths

23.4.5    Key Opportunities

 

23.5        Nuvectra

23.5.1    Business Overview

23.5.2    Product Offerings

23.5.3    Key Strategies

23.5.4    Key Strengths

23.5.5    Key Opportunities

 

23.6        Saluda Medical

23.6.1    Business Overview

23.6.2    Product Offerings

23.6.3    Key Strategies

23.6.4    Key Strengths

23.6.5    Key Opportunities

 

23.7        SceneRay

23.7.1    Business Overview

23.7.2    Product Offerings

23.7.3    Key Strategies

23.7.4    Key Strengths

23.7.5    Key Opportunities

 

23.8        Stimwave

23.8.1    Business Overview

23.8.2    Product Offerings

23.8.3    Key Strategies

23.8.4    Key Strengths

23.8.5    Key Opportunities

 

24           Investigational Companies

 

24.1        GTX Medical

24.1.1    Business Overview

24.1.2    Investigational Products

 

24.2        MicroTransponder

24.2.1    Business Overview

24.2.2    Investigational Products

 

24.3        Neuralink

24.3.1    Business Overview

24.3.2    Investigational Products

 

24.4        SetPoint Medical

24.4.1    Business Overview

24.4.2    Investigational Products

 

24.5        Synchron

24.5.1    Business Overview

24.5.2    Investigational Products

 

25           Report Summary

25.1        Key Takeaways

25.2        Strategic Recommendations

 

26           Quantitative Summary

26.1        Product

26.2        Application

26.3        End-User

26.4        Geography

26.5        North America: Product Segmentation

26.6        Europe: Product Segmentation

26.7        APAC: Product Segmentation

26.8        Latin America: Product Segmentation

26.9        Middle East & Africa: Product Segmentation

26.1        SCS: Geography Segmentation

26.11     DBS: Geography Segmentation

26.12     VNS: Geography Segmentation

 

27           Appendix

27.1        Abbreviations

Exhibit 1               Segmentation of Global Neural Implants Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Types of Neural Implant Devices

Exhibit 4               Global Neural Implants Market by Geography 2019 (%)

Exhibit 5               Global Neural Implants Market by Product 2019 (%)

Exhibit 6               Impact of Emergence of Latest Generation Neural Implants

Exhibit 7               Impact of Promising Investigational Devices

Exhibit 8               Impact of New Product Approvals/Launches

Exhibit 9               Impact of Rising Target Patient Pool Globally

Exhibit 10             Parkinson's Disease Death Rate in US 2010−2017 (per 100,000 population)

Exhibit 11             Number of Epilepsy Cases Worldwide by Region 2016

Exhibit 12             Impact of Growing Popularity of MR-conditional Neural Implants

Exhibit 13             Impact of Increasing Uptake of Minimally Invasive Pain Relief Treatment

Exhibit 14             Key Benefits of Minimally Invasive Chronic Pain Management with SCS

Exhibit 15             Impact of Use of High-Frequency Neuromodulation Therapy

Exhibit 16             Key Benefits of Paresthesia-free Therapy over Traditional SCS Treatment

Exhibit 17             Impact of Risks & Complications Associated with Neural Implants

Exhibit 18             Potential Complications Related to DBS

Exhibit 19             Potential Complications Related to SCS

Exhibit 20             Impact of Stringent Regulations Associated with Neural Implants

Exhibit 21             Key Recommendations to Healthcare Providers by FDA for SCS

Exhibit 22             Major Actions/Sanctions Imposed on Manufacturers by Regulatory Bodies

Exhibit 23             Impact of Limited Availability of Skilled Neurologists/Neurosurgeons

Exhibit 24             Impact of High Cost of Neural Implants

Exhibit 25             Key Factors Affecting the Cost of DBS Procedure

Exhibit 26             Global Neural Implants Market 2019–2025 ($ million)

Exhibit 27             Global Neural Implants Market by Geography

Exhibit 28             Global Neural Implants Market by Product

Exhibit 29             Global Neural Implants Market by Application

Exhibit 30             Global Neural Implants Market by End-user

Exhibit 31             Five Forces Analysis 2019

Exhibit 32             Incremental Growth by Product 2019 & 2025

Exhibit 33             Global Neural Implants Market by Product

Exhibit 34             Global Market by Product: Incremental Growth

Exhibit 35             Global Market by Product: Absolute Growth

Exhibit 36             Global Neural Implants Market by SCS: Incremental & Absolute Growth

Exhibit 37             Potential Benefits Offered by SCS

Exhibit 38             Global Market by SCS 2019–2025 ($ million)

Exhibit 39             Incremental Growth by Geography 2019 & 2025

Exhibit 40             Global Neural Implants Market by DBS: Incremental & Absolute Growth

Exhibit 41             Global Market by DBS 2019–2025 ($ million)

Exhibit 42             Incremental Growth by Geography 2019 & 2025

Exhibit 43             Global Neural Implants Market by VNS: Incremental & Absolute Growth

Exhibit 44             The FDA Approved Indications for VNS in Adults

Exhibit 45             Global Market by VNS 2019–2025 ($ million)

Exhibit 46             Incremental Growth by Geography 2019 & 2025

Exhibit 47             Incremental Growth by Application 2019 & 2025

Exhibit 48             Global Neural Implants Market by Application

Exhibit 49             Global Market by Application: Incremental Growth

Exhibit 50             Global Market by Application: Absolute Growth

Exhibit 51             Global Neural Implants Market by Chronic Pain: Incremental & Absolute Growth

Exhibit 52             Global Market by Chronic Pain 2019–2025 ($ million)

Exhibit 53             Global Neural Implants Market by PD: Incremental & Absolute Growth

Exhibit 54             Global Market by PD 2019–2025 ($ million)

Exhibit 55             Global Neural Implants Market by Epilepsy: Incremental & Absolute Growth

Exhibit 56             Global Market by Epilepsy 2019–2025 ($ million)

Exhibit 57             Global Neural Implants Market by Others: Incremental & Absolute Growth

Exhibit 58             Global Market by Others 2019–2025 ($ million)

Exhibit 59             Incremental Growth by End-user 2019 & 2025

Exhibit 60             Global Neural Implants Market by End-user

Exhibit 61             Global Market by End-user: Incremental Growth

Exhibit 62             Global Market by End-user: Absolute Growth

Exhibit 63             Global Neural Implants Market by Hospitals: Incremental & Absolute Growth

Exhibit 64             Global Market by Hospitals 2019–2025 ($ million)

Exhibit 65             Global Neural Implants Market by Specialized Neurological Centers: Incremental & Absolute Growth

Exhibit 66             Global Market by Specialty Neurological Centers 2019–2025 ($ million)

Exhibit 67             Global Neural Implants Market by Outpatient Surgery Centers: Incremental & Absolute Growth

Exhibit 68             Global Market by Outpatient Surgery Centers 2019–2025 ($ million)

Exhibit 69             Incremental Growth by Geography 2019 & 2025

Exhibit 70             Global Neural Implants Market by Geography

Exhibit 71             Global Market by Geography 2019: Key Countries ($ million)

Exhibit 72             Global Market by Geography: Incremental Growth

Exhibit 73             Global Market by Geography: Absolute Growth

Exhibit 74             North America Neural Implants Market in 2019

Exhibit 75             North America Market: Absolute & Incremental Growth

Exhibit 76             Market in North America 2019–2025 ($ million)

Exhibit 77             Incremental Growth by Product 2019 & 2025

Exhibit 78             Incremental Growth in North America 2019 & 2025

Exhibit 79             Percentage of PD patients who Utilized Several Resources to Manage PD in US (2019)

Exhibit 80             Market in US 2019–2025 ($ million)

Exhibit 81             Market in Canada 2019–2025 ($ million)

Exhibit 82             Europe Neural Implants Market in 2019

Exhibit 83             Market in Europe: Incremental & Absolute Growth

Exhibit 84             Market in Europe 2019–2025 ($ million)

Exhibit 85             Incremental Growth by Product 2019 & 2025

Exhibit 86             Incremental Growth in Europe 2019 & 2025

Exhibit 87             Market in Germany 2019–2025 ($ million)

Exhibit 88             Market in France 2019–2025 ($ million)

Exhibit 89             Market in UK 2019–2025 ($ million)

Exhibit 90             Market in Italy 2019–2025 ($ million)

Exhibit 91             ants Market in Spain 2019–2025 ($ million)

Exhibit 92             APAC Neural Implants Market in 2019

Exhibit 93             APAC Market: Incremental & Absolute Growth

Exhibit 94             Market in APAC 2019–2025 ($ million)

Exhibit 95             Population Demographics in APAC

Exhibit 96             Health Access & Quality Index Score for Key APAC Countries 2016

Exhibit 97             Incremental Growth by Product 2019 & 2025

Exhibit 98             Incremental Growth in APAC 2019 & 2025

Exhibit 99             Market in Japan 2019–2025 ($ million)

Exhibit 100          Market in China 2019–2025 ($ million)

Exhibit 101          Market in Australia 2019–2025 ($ million)

Exhibit 102          Market in South Korea 2019–2025 ($ million)

Exhibit 103          Market in India 2019–2025 ($ million)

Exhibit 104          Latin America Neural Implants Market in 2019

Exhibit 105          Market in Latin America: Incremental & Absolute Growth

Exhibit 106          Market in Latin America 2019–2025 ($ million)

Exhibit 107          Incremental Growth by Product 2019 & 2025

Exhibit 108          Incremental Growth in Latin America 2019 & 2025

Exhibit 109          Market in Brazil 2019–2025 ($ million)

Exhibit 110          Market in Mexico 2019–2025 ($ million)

Exhibit 111          Market in Argentina 2019–2025 ($ million)

Exhibit 112          Middle East & Africa Neural Implants Market in 2019

Exhibit 113          Middle East & Africa Market: Incremental & Absolute Growth

Exhibit 114          Market in Middle East & Africa 2019–2025 ($ million)

Exhibit 115          Incremental Growth by Product 2019 & 2025

Exhibit 116          Incremental Growth in Middle East & Africa 2019 & 2025

Exhibit 117          Market in Turkey 2019–2025 ($ million)

Exhibit 118          Market in Saudi Arabia 2019–2025 ($ million)

Exhibit 119          Market in South Africa 2019–2025 ($ million)

Exhibit 120          Market in Iran 2019–2025 ($ million)

Exhibit 121          Global Neural Implants Market: Vendors Market Share (2019)

Exhibit 122          Medtronic: R&D Expenditure 2017−2019 ($ million)

Exhibit 123          Medtronic: Revenue by Segments 2018 & 2019 ($ million)

Exhibit 124          Medtronic: Revenue by Geography 2019 (%)

Exhibit 125          Abbott: R&D Expenditure 2017−2019 ($ million)

Exhibit 126          Abbott: Revenue by Segment 2018 & 2019 ($ million)

Exhibit 127          Abbott: Revenue by Geography 2019 (%)

Exhibit 128          Boston Scientific: R&D Expenditure 2017−2019 ($ million)

Exhibit 129          Boston Scientific: Revenue by Segment 2018 & 2019 ($ million)

Exhibit 130          Boston Scientific: Revenue by Geography 2019 (%)

Exhibit 131          NEVRO: R&D Expenditure 2017−2019 ($ million)

Exhibit 132          NEVRO: Revenue by Geography 2019 (%)

Exhibit 133          LivaNova: R&D Expenditure 2017−2019 ($ million)

Exhibit 134          LivaNova: Revenue by Segment 2018 & 2019 ($ million) 

               

LIST OF TABLES 

 

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2019

Table 3                  Key Investigational Neural Implants

Table 4                  List of New Product Approvals/Launches

Table 5                  Few Key Commercially Available MR Conditional Neural Implants

Table 6                  Estimated Health Worker Needs-Based Shortages by Region, 2013 & 2030 (million)

Table 7                  Country wise Estimated Cost of DBS Procedure

Table 8                  Significant Players Offering SCS Devices

Table 9                  Significant Players Offering DBS Devices

Table 10               Significant Players Offering VNS Devices

Table 11               Major Factors Associated with the Development of Chronic Pain

Table 12               Key Neural Implants for Chronic Pain by Significant Players

Table 13               Key Neural Implants for PD Offered by Significant Players

Table 14               Key Neural Implants for Epilepsy Offered by Significant Players

Table 15               Key Neural Implants for Others Offered by Significant Players

Table 16               Provincial Reimbursement Policy in China

Table 17               Typical Cost of DBS including Surgery, Inpatient Stay, and Follow-ups in India Compared to Developed Countries

Table 18               Key Competitive Factors in the Global Neural Implants Market

Table 19               Global Neural Implants Market: Vendors Ranking 2019

Table 20               Medtronic: Major Product Offerings

Table 21               Abbott: Major Product Offerings

Table 22               Boston Scientific: Major Product Offerings

Table 23               NEVRO: Major Product Offerings

Table 24               LivaNova: Major Product Offerings

Table 25               Aleva Neurotherapeutics: Major Product Offerings

Table 26               Beijing PINS Medical: Major Product Offerings

Table 27               Nalu Medical: Major Product Offerings

Table 28               NeuroPace: Major Product Offerings

Table 29               Nuvectra: Major Product Offerings

Table 30               Saluda Medical: Major Product Offerings

Table 31               SceneRay: Major Product Offerings

Table 32               Stimwave: Major Product Offerings

Table 33               GTX Medical: Major Product Offerings

Table 34               MicroTransponder: Major Product Offerings

Table 35               Neuralink: Major Product Offerings

Table 36               SetPoint Medical: Major Product Offerings

Table 37               Synchron: Major Product Offerings

Table 38               Global Neural Implants Market by Product 2019−2025 ($ million)

Table 39               Global Market by Product 2019−2025 (%)

Table 40               Global Neural Implants Market by Application 2019−2025 ($ million)

Table 41               Global Market by Application 2019−2025 (%)

Table 42               Global Neural Implants Market by End-user 2019−2025 ($ million)

Table 43               Global Market by End-user 2019−2025 (%)

Table 44               Global Neural Implants Market by Geography 2019−2025 ($ million)

Table 45               Global Market by Geography 2019−2025 (%)

Table 46               North America Neural Implants Market by Product 2019−2025 ($ million)

Table 47               North America Market by Product 2019−2025 (%)

Table 48               Europe Neural Implants Market by Product 2019−2025 ($ million)

Table 49               Europe Market by Product 2019−2025 (%)

Table 50               APAC Neural Implants Market by Product 2019−2025 ($ million)

Table 51               APAC Market by Product 2019−2025 (%)

Table 52               Latin America Neural Implants Market by Product 2019−2025 ($ million)

Table 53               Latin America Market by Product 2019−2025 (%)

Table 54               Middle East & Africa Neural Implants Market by Product 2019−2025 ($ million)

Table 55               Middle East & Africa Market by Product 2019−2025 (%)

Table 56               SCS Neural Implants Market by Geography 2019−2025 ($ million)

Table 57               SCS Market by Geography 2019−2025 (%)

Table 58               DBS Neural Implants Market by Geography 2019−2025 ($ million)

Table 59               DBS Market by Geography 2019−2025 (%)

Table 60               VNS Neural Implants Market by Geography 2019−2025 ($ million)

Table 61               VNS Market by Geography 2019−2025 (%)

Select a license type that suits your business needs

Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Our Clients

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date